Editorial content

Watch Now: Innovating for ophthalmic diseases

Three expert speakers discuss the latest advances from their companies: Healios K.K., Apellis and Mannin Research.

Go to the profile of Samia Burridge
Aug 22, 2016
Upvote 6 Comment

The increased need for more effective treatments for diseases of the eye such as glaucoma, macular degeneration and dry eye, coupled with technological advances in areas such as regenerative medicine, are providing exciting opportunities for companies to develop new eye care products.

This webcast will explore some of the latest advances in the ophthalmic field through discussion with representatives from companies developing a range of innovative therapies for eye disorders, including the use of iPS cells, eye drops to deliver small-molecule drugs and complement inhibition.

The webcast will conclude with a live roundtable discussion and a Q&A section to allow you to participate and put your own questions to the speakers.

Sign up now to watch this live or in your own time:


If you’d like to be kept informed of upcoming webcast topics, and you are a member of this site, simply follow me for updates. If you’re not yet a member, you can register for the BioPharma Dealmakers e-alert here

Find out more about how your company can take part in a Nature.com Webcast.

Go to the profile of Samia Burridge

Samia Burridge

Business Development Manager, Nature Research Group

See my linkedIn profile for Bio/Expertise

No comments yet.